IMMUNOVANT (IMVT)
$18.24
0.55 (3.02%)
IMVT Stock Earnings: Immunovant Misses EPS for Q4 2024
IMVT stock results show that Immunovant missed analyst estimates for earnings per share the fourth quarter of 2024.

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$17.89
Market Cap
3.19B
PE Ratio
-8.69
EPS
-2.0983
Volume (Avg. Vol.)
1.14M
Day's Range
$17.83 - $18.96
52-Week Range
$17.01 - $34.47
Dividend & Yield
N/A (N/A)